Bausch + Lomb Corp - BLCO Net earnings per one share for the last twelve months

Public company logo of Bausch Health (BLCO)

Bausch + Lomb Corporation (BLCO) is scaling profits through the automation of lens production and the mass distribution of ophthalmological products. The TTM net income per share growth rate allows for the real-time tracking of business efficiency, with the value currently holding at 63.20. Growth prospects are based on strategic alliances with clinics and the company's pricing power to increase prices without losing customer loyalty.

BLCO bausch.com: Net earnings per share (EPS TTM) in the range 02/11/2024 - 11/18/2026

Financial and market metric breakdowns for Bausch Health (BLCO)

Initial company analysis:BLCO (Bausch + Lomb)
Mass-produced product of Bausch + Lomb Corp

When screening for issuer reliability, this indicator assesses the trend of net income per share over the last twelve months relative to the previous year, reflecting actual profit generation efficiency. By analyzing the annual shift in EPS TTM, an investor can see the results of Brent Saunders' asset portfolio transformation, where growth in this metric confirms the success of business optimization at Bausch + Lomb Corporation (BLCO).

Competitor analysis for Bausch + Lomb Corporation

Net earnings per one share for the last twelve months Alcon Inc|GKOS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Apellis Corp (APLS)|Earnings per share for the last twelve months Belite Bio|ocutx.com (OCUL) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) HROW|Earnings per share for the last twelve months VRDN (Viridian Therapeutics, Inc.)|Net earnings per share (EPS TTM) LENZ (lenz-tx.com)|Net earnings per share (EPS TTM) oculis.com OCS|EyePoint Pharmaceuticals Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Kodiak Sciences Inc. KOD|ALDX: Net earnings per share (EPS TTM)|KALA BIO, Inc. (KALA) - Net earnings per share (EPS TTM)|IRD (Opus Genetics Inc) - Net earnings per share (EPS TTM)|OKYO: Earnings per share for the trailing year|Net earnings per share for the last 12 months ADVM (adverum.com)|OTLK - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CLSD (Clearside Biomedical Inc)|Earnings per share for the trailing year NBY|Kiora Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ALIM (Alimera Sciences, Inc.)|EYEN (Eyenovia Corp) - Net earnings per share for the last 12 months|Guardion Health Science - Earnings per share for the trailing year|Earnings per share for the last twelve months Ocuphire Pharma, Inc.|Opthea Ltd. (OPT) - Net earnings per share for the last four quarters